Published in Br J Cancer on May 01, 2007
ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen. Br J Cancer (2008) 1.06
Current approaches to gastric cancer in Korea. Gastrointest Cancer Res (2008) 0.90
Non-platinum-based chemotherapy for treatment of advanced gastric cancer: 5-fluorouracil, taxanes, and irinotecan. World J Gastroenterol (2014) 0.79
Serum VEGFR-3 and survival of advanced gastric cancer patients treated with FOLFOX. World J Gastroenterol (2010) 0.78
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst (2000) 133.74
Optimal two-stage designs for phase II clinical trials. Control Clin Trials (1989) 21.03
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol (2006) 20.28
Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. Cancer Res Treat (2005) 11.27
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol (2006) 9.16
Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol (2006) 7.21
Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol (2004) 6.47
Cancer statistics, 1994. CA Cancer J Clin (1994) 4.14
Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am (2002) 3.69
Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma. J Clin Oncol (2005) 2.52
Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients. J Clin Oncol (2002) 2.15
Disparities in gastric cancer chemotherapy between the East and West. J Clin Oncol (2006) 1.88
Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study. J Clin Oncol (2000) 1.77
Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine. J Clin Oncol (1998) 1.72
Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol (2003) 1.64
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. Br J Cancer (2005) 1.61
Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer. J Clin Oncol (1998) 1.61
Synergistic antitumor activity of capecitabine in combination with irinotecan. Clin Colorectal Cancer (2005) 1.43
Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer. Br J Cancer (2005) 1.31
A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer. Ann Oncol (2004) 1.27
A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity. Ann Oncol (2005) 1.20
A phase I/II and pharmacokinetic study of irinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer. Ann Oncol (2005) 1.17
A pilot phase II study of capecitabine in advanced or recurrent gastric cancer. Oncology (2003) 1.16
Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer. Br J Cancer (2005) 1.12
Cellular interactions of 5-fluorouracil and the camptothecin analogue CPT-11 (irinotecan) in a human colorectal carcinoma cell line. Biochem Pharmacol (1998) 1.10
Therapeutic synergy between irinotecan and 5-fluorouracil against human tumor xenografts. Clin Cancer Res (2004) 1.09
Effect of adding the topoisomerase I poison 7-ethyl-10-hydroxycamptothecin (SN-38) to 5-fluorouracil and folinic acid in HCT-8 cells: elevated dTTP pools and enhanced cytotoxicity. Cancer Chemother Pharmacol (1998) 0.93
Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancer. Ann Oncol (2002) 0.93
FOLFOX-4 regimen as fist-line chemotherapy in elderly patients with advanced gastric cancer: a safety study. J Chemother (2007) 0.90
Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: a Korean Cancer Study Group trial. Acta Oncol (2005) 0.87
First-line chemotherapy with irinotecan plus capecitabine for advanced colorectal cancer. Oncology (2004) 0.85
Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen: two parallel randomized phase II studies. Cancer (1998) 0.84
A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma. Br J Cancer (2006) 0.84
Phase II study of weekly irinotecan plus capecitabine for chemotherapy-naive patients with advanced nonsmall cell lung carcinoma. Cancer (2005) 0.81
Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer. Br J Cancer (2006) 0.80
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res (1999) 4.23
Molecular mechanism for duplication 17p11.2- the homologous recombination reciprocal of the Smith-Magenis microdeletion. Nat Genet (2000) 3.80
A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science (2000) 3.72
Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s. Transcriptional and post-transcriptional regulation of the rat enzyme. J Biol Chem (1986) 3.39
Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J Biol Chem (2001) 3.27
Preventing ventricular fibrillation by flattening cardiac restitution. Proc Natl Acad Sci U S A (2000) 3.15
Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF. Mol Ther (2006) 3.09
Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infect (2006) 3.04
Endobronchial tuberculosis. Clinical and bronchoscopic features in 121 cases. Chest (1992) 2.83
Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene (2008) 2.83
Electron microscope heteroduplex study of sequence relations of T2, T4, and T6 bacteriophage DNAs. Virology (1974) 2.82
Syndrome of cerebral spinal fluid hypovolemia: clinical and imaging features and outcome. Neurology (2000) 2.76
The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol (2000) 2.57
Heteroduplex structures of bacteriophage Mu DNA. Virology (1973) 2.52
A large-scale distributed network for covert spatial attention: further anatomical delineation based on stringent behavioural and cognitive controls. Brain (1999) 2.51
Hunger selectively modulates corticolimbic activation to food stimuli in humans. Behav Neurosci (2001) 2.49
Abnormal cardiac conduction and morphogenesis in connexin40 and connexin43 double-deficient mice. Circ Res (2000) 2.37
Pollen tube guidance by the female gametophyte. Development (1997) 2.22
D-Fucose as a gratuitous inducer of the L-arabinose operon in strains of Escherichia coli B-r mutant in gene araC. J Bacteriol (1971) 2.18
Endoscopic resection of submucosal tumor of the esophagus: results in 62 patients. Endoscopy (1997) 2.11
Abdominal amyloidosis: spectrum of radiological findings. Clin Radiol (2003) 2.10
Incidence and natural history of deep-vein thrombosis after total hip arthroplasty. A prospective and randomised clinical study. J Bone Joint Surg Br (2003) 2.10
Increased incidence of herpes zoster in the setting of cytomegalovirus preemptive therapy after kidney transplantation. Transpl Infect Dis (2013) 2.09
Thrombotic thrombocytopenic purpura associated with ticlopidine use: a report of 3 cases and review of the literature. Arch Intern Med (1999) 2.08
Rapid appearance of new cerebral microbleeds after acute ischemic stroke. Neurology (2009) 2.08
Measurement of cell proliferation by labeling of DNA with stable isotope-labeled glucose: studies in vitro, in animals, and in humans. Proc Natl Acad Sci U S A (1998) 2.05
Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B. Neurology (2011) 2.03
Burkitt lymphoma in the mouse. J Exp Med (2000) 1.96
Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patients. AJNR Am J Neuroradiol (2008) 1.93
The liposhaver in facial plastic surgery. A multi-institutional experience. Arch Otolaryngol Head Neck Surg (1996) 1.91
Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci U S A (2001) 1.90
Biliary papillomatosis: clinical, cholangiographic and cholangioscopic findings. Endoscopy (1998) 1.85
Mitochondrial DNA content is decreased in autosomal dominant optic atrophy. Neurology (2005) 1.81
Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol (2001) 1.80
Which cholesterol level is related to the lowest mortality in a population with low mean cholesterol level: a 6.4-year follow-up study of 482,472 Korean men. Am J Epidemiol (2000) 1.79
6,7-Bis(bromomethyl)-2,11,18,21,24-pentaoxatetracyclo. Acta Crystallogr C (2001) 1.79
A novel cold-inducible zinc finger protein from soybean, SCOF-1, enhances cold tolerance in transgenic plants. Plant J (2001) 1.74
Rotational vertebral artery syndrome: oculographic analysis of nystagmus. Neurology (2005) 1.73
The homeodomain protein NK-3 recruits Groucho and a histone deacetylase complex to repress transcription. J Biol Chem (1999) 1.71
High-resolution crystal structures of delta5-3-ketosteroid isomerase with and without a reaction intermediate analogue. Biochemistry (1997) 1.71
Comparison of endoscopic ultrasonography and conventional endoscopy for prediction of depth of tumor invasion in early gastric cancer. Endoscopy (2010) 1.70
Relation between cellular repolarization characteristics and critical mass for human ventricular fibrillation. J Cardiovasc Electrophysiol (1999) 1.69
A comparison of polyethylene wear in hips with cobalt-chrome or zirconia heads. A prospective, randomised study. J Bone Joint Surg Br (2001) 1.68
Spatiotemporal heterogeneity in the induction of ventricular fibrillation by rapid pacing: importance of cardiac restitution properties. Circ Res (1999) 1.67
Suppression of the Fix- phenotype of Rhizobium meliloti exoB mutants by lpsZ is correlated to a modified expression of the K polysaccharide. J Bacteriol (1995) 1.66
Phospholipase C isozymes selectively couple to specific neurotransmitter receptors. Nature (1997) 1.66
The evolutionary chromosome translocation 4;19 in Gorilla gorilla is associated with microduplication of the chromosome fragment syntenic to sequences surrounding the human proximal CMT1A-REP. Genome Res (2001) 1.64
Virulence factors of Helicobacter pylori in Korean isolates do not influence proinflammatory cytokine gene expression and apoptosis in human gastric epithelial cells, nor do these factors influence the clinical outcome. J Gastroenterol (2000) 1.62
Involvement of specific calmodulin isoforms in salicylic acid-independent activation of plant disease resistance responses. Proc Natl Acad Sci U S A (1999) 1.61
Strongyloides stercoralis hyperinfection in a patient with the acquired immune deficiency syndrome. Am J Med (1987) 1.61
A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients. Am J Transplant (2011) 1.60
CT differentiation of tuberculous peritonitis and peritoneal carcinomatosis. AJR Am J Roentgenol (1996) 1.59
Comparison of total hip replacement with and without cement in patients younger than 50 years of age: the results at 18 years. J Bone Joint Surg Br (2011) 1.57
Distribution and regulation of telencephalic aromatase expression in the zebra finch revealed with a specific antibody. J Comp Neurol (2000) 1.57
Defective vascular development in connexin 45-deficient mice. Development (2000) 1.57
Strain distribution in the proximal human femur. An in vitro comparison in the intact femur and after insertion of reference and experimental femoral stems. J Bone Joint Surg Br (2001) 1.56
Central neurocytoma: proliferative potential and biological behavior. J Neurosurg (1996) 1.55
IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death. J Immunol (2001) 1.55
Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem Pharmacol (1999) 1.55
Head-shaking nystagmus in lateral medullary infarction: patterns and possible mechanisms. Neurology (2007) 1.54
Impregnation of vancomycin, gentamicin, and cefotaxime in a cement spacer for two-stage cementless reconstruction in infected total hip arthroplasty. J Arthroplasty (2001) 1.51
Treatment of intertrochanteric fracture with the Gamma AP locking nail or by a compression hip screw--a randomised prospective trial. Int Orthop (1998) 1.50
Stimulation of humoral and cell mediated immunity by polysaccharide from mushroom Phellinus linteus. Int J Immunopharmacol (1996) 1.50
Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann Oncol (2007) 1.50
Differential expression of senescence-associated mRNAs during leaf senescence induced by different senescence-inducing factors in Arabidopsis. Plant Mol Biol (1998) 1.49
Phacoemulsification with a bevel-down phaco tip: phaco-drill. J Cataract Refract Surg (1997) 1.49
Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma. Cancer (1999) 1.48
Efficacy of Helicobacter pylori eradication therapy in chronic liver disease. Dig Liver Dis (2008) 1.48
Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett (1980) 1.48
Primary stenting for acute myocardial infarction via the transradial approach: a safe and useful alternative to the transfemoral approach. J Invasive Cardiol (2000) 1.47
Phenylpropanolamine contained in cold remedies and risk of hemorrhagic stroke. Neurology (2007) 1.47
Cerebral microbleeds are regionally associated with intracerebral hemorrhage. Neurology (2004) 1.46
Relation between ligament of Marshall and adrenergic atrial tachyarrhythmia. Circulation (1999) 1.45
Association of angiotensin I converting enzyme gene polymorphism with reflux nephropathy in children. Nephron (2000) 1.44
Alfentanil reduces the febrile response to interleukin-2 in humans. Crit Care Med (2000) 1.44
A new hereditary cataract mouse with lens rupture. Lab Anim (1997) 1.44
Identification of deoxynivalenol- and nivalenol-producing chemotypes of Gibberella zeae by using PCR. Appl Environ Microbiol (2001) 1.43
Diagnosis of coronary vasospasm in patients with clinical presentation of unstable angina pectoris using ergonovine echocardiography. Am J Cardiol (1998) 1.43
Differential effects of cAMP in neurons and astrocytes. Role of B-raf. J Biol Chem (1999) 1.43
Idiopathic multilocular thymic cyst: CT features with clinical and histopathologic correlation. AJR Am J Roentgenol (2001) 1.42
Single-stage operation for bilateral middle cerebral artery aneurysms. Acta Neurochir (Wien) (2005) 1.42
Production of cell-associated polysaccharides of Rhizobium fredii USDA205 is modulated by apigenin and host root extract. Mol Plant Microbe Interact (1994) 1.42
Cerebral glucose metabolism in Fisher syndrome. J Neurol Neurosurg Psychiatry (2008) 1.42
Anomalous subaortic position of the brachiocephalic vein (innominate vein): an echocardiographic study. Br Heart J (1990) 1.42
Bacteriophage T4 transfer RNA. 3. Clustering of the genes for the T4 transfer RNA's. J Mol Biol (1972) 1.41
Optimal bolus dose of alfentanil for successful tracheal intubation during sevoflurane induction with and without nitrous oxide in children. Br J Anaesth (2010) 1.41
Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood (2001) 1.39
Pulmonary function studies in patients with upper airway obstruction. Am Rev Respir Dis (1972) 1.39
Wedge resection and modified mattress suture for correcting anterior septal deviation: how we do it. Clin Otolaryngol (2011) 1.38
Comparison of fixed-bearing and mobile-bearing total knee arthroplasties. Clin Orthop Relat Res (2001) 1.38
False-positive growth of Mycobacterium tuberculosis attributable to laboratory contamination confirmed by restriction fragment length polymorphism analysis. Int J Tuberc Lung Dis (2001) 1.38
Long-term clinical course and prognostic factors in intestinal Behçet's disease. Dis Colon Rectum (2000) 1.37